Design Therapeutics (DSGN) Net Margin (2020)
Historic Net Margin for Design Therapeutics (DSGN) over the last 1 years, with Q4 2020 value amounting to 11700.0%.
- Design Therapeutics' Net Margin changed N/A to 11700.0% in Q4 2020 from the same period last year, while for Sep 2021 it was 11700.0%, marking a year-over-year change of. This contributed to the annual value of 3685.84% for FY2020, which is N/A changed from last year.
- Latest data reveals that Design Therapeutics reported Net Margin of 11700.0% as of Q4 2020.
- Over the past 5 years, Design Therapeutics' Net Margin peaked at 438.73% during Q1 2020, and registered a low of 11915.0% during Q3 2020.